CA2586175C - Isapose anticancereux et procede de separation d'enantiomere utile pour synthetiser ledit compose - Google Patents

Isapose anticancereux et procede de separation d'enantiomere utile pour synthetiser ledit compose Download PDF

Info

Publication number
CA2586175C
CA2586175C CA2586175A CA2586175A CA2586175C CA 2586175 C CA2586175 C CA 2586175C CA 2586175 A CA2586175 A CA 2586175A CA 2586175 A CA2586175 A CA 2586175A CA 2586175 C CA2586175 C CA 2586175C
Authority
CA
Canada
Prior art keywords
cr13r14
aryl
alkyl
group
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2586175A
Other languages
English (en)
Other versions
CA2586175A1 (fr
Inventor
Bingwei Vera Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
OSI Pharmaceuticals LLC
Original Assignee
Pfizer Inc
OSI Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc, OSI Pharmaceuticals LLC filed Critical Pfizer Inc
Priority claimed from CA002398353A external-priority patent/CA2398353C/fr
Publication of CA2586175A1 publication Critical patent/CA2586175A1/fr
Application granted granted Critical
Publication of CA2586175C publication Critical patent/CA2586175C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

CA2586175A 2000-01-21 2000-11-29 Isapose anticancereux et procede de separation d'enantiomere utile pour synthetiser ledit compose Expired - Fee Related CA2586175C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17771800P 2000-01-21 2000-01-21
US60/177,718 2000-01-21
CA002398353A CA2398353C (fr) 2000-01-21 2000-11-29 Isapose anticancereux et procede de separation d'enantiomere utile pour synthetiser ledit compose

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002398353A Division CA2398353C (fr) 2000-01-21 2000-11-29 Isapose anticancereux et procede de separation d'enantiomere utile pour synthetiser ledit compose

Publications (2)

Publication Number Publication Date
CA2586175A1 CA2586175A1 (fr) 2001-07-26
CA2586175C true CA2586175C (fr) 2010-12-14

Family

ID=38319527

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2586175A Expired - Fee Related CA2586175C (fr) 2000-01-21 2000-11-29 Isapose anticancereux et procede de separation d'enantiomere utile pour synthetiser ledit compose

Country Status (1)

Country Link
CA (1) CA2586175C (fr)

Also Published As

Publication number Publication date
CA2586175A1 (fr) 2001-07-26

Similar Documents

Publication Publication Date Title
CA2398353C (fr) Isapose anticancereux et procede de separation d'enantiomere utile pour synthetiser ledit compose
US6258824B1 (en) Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents
EP1106612B1 (fr) Derivés de Quinoline comme inhibiteurs de la proteine Farnesyle transferase
US6844357B2 (en) Substituted quinolin-2-one derivatives useful as antiproliferative agents
KR100816166B1 (ko) 항증식제로서 유용한 신규한 벤조이미다졸린 유도체
CA2610661A1 (fr) Combinaisons d'inhibiteurs d'erbb2 avec d'autres agents therapeutiques dans le traitement du cancer
WO2005044302A1 (fr) Associations selectives d'un inhibiteur de erbb2 et d'un anticorps anti-erbb dans le traitement du cancer
CA2586175C (fr) Isapose anticancereux et procede de separation d'enantiomere utile pour synthetiser ledit compose
CA2381513C (fr) Derives de 4-amino-pyridopyrimidine bicyclique substituee
MXPA01008154A (en) Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents
ZA200501353B (en) Novel benzoimidazole derivatives useful as antiproliferative agents

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20121129